The Screen4Care project, an innovative European research initiative, has launched recruitment for its newborn screening program aimed at improving the early diagnosis of rare genetic diseases. The project introduces a Next-Generation Sequencing (NGS)-based screening program focused on the early detection of treatable rare diseases caused by genetic mutations in 245 specific genes.
Recruitment is currently open at the birth site of Ferrara, Italy. Additional sites in Rome (Italy), Freiburg, Erlangen, and Goettingen (Germany), and Dijon (France) are expected to begin recruiting newborns for the program by the end of January 2025. Further sites are likely to be added, with updates available on the Screen4Care website.
For more information, please visit: Screen4Care Official Website.